FEATURES OF DEVELOPMENT, COURSE AND OUTCOME OF ACUTE KIDNEY INJURY AFTER HEMOPOIETIC STEM CELL TRANSPLANTATION IN CHILDREN (LITERATURE REWIEV)
https://doi.org/10.24884/1561-6274-2018-22-3-18-25
Abstract
In literature review are presented the epidemiology, causes, features of courses, outcome of acute kidney injury after hemopoietic stem cell transplantation in children.
About the Authors
E. R. Kharisova
St-Petersburg State Pediatric Medical University
Russian Federation
MD, StPetersburg State Pediatric Medical University Department of faculty pediatrics
Russian Federation
MD, StPetersburg State Pediatric Medical University Department of faculty pediatrics
N. D. Savenkova
St-Petersburg State Pediatric Medical University
Russian Federation
State Pediatric Medical Department of faculty pediatrics University
Russian Federation
State Pediatric Medical Department of faculty pediatrics University
References
1. Afanasev BV, Zubarovskaya LS, Moiseev IS. Allogennaya transplantaciya gemopoehticheskih stvolovyh kletok u detej-nastoyashchee problemy perspektivy. Rossijskij zhurnal detskoj gematologii i onkologii2015; 2: 28–42 DOI: 10.17650/2311-1267-2015-2-2-28-42
2. Zubarovskaya LS, Afanas’ev BV. Transplantaciya gemopoehticheskih stvolovyh kletok pri gematologicheskih zabolevaniyah. Gematologiya. Rukovodstvo dlya vrachej. Afanas’ev BV, Volkova OYа, Ganapiev AA i dr. SPb.: SpecLit, 2011; 537–591
3. Smirnov KA. Ostroe povrezhdenie pochek posle transplantacii gemopoehticheskih stvolovyh kletok. Smirnov AV, Dobronravov VA, Rumyancev ASH, Kayukov IG. Ostroe povrezhdenie pochek. Medicinskoe informacionnoe agenstvo, М., 2015; 446–467
4. Smirnov KA, Dobronravov VA. Ostroe povrezhdenie pochek pri transplantacii gemopoehticheskih stvolovyh kletok. Nefrologiya 2014; 6:26–42
5. Zager RA, O’Quigley J, Zager BK et al. Acute renal failure following bone marrow transplantation: a retrospective study of 272 patients. Am J Kidney Dis1989; 13:210–216
6. Lane PH, Mauer SM, Blazar BR et al. Outcome of dialysis for acute renal failure in pediatric bone marrow transplant patients. Bone Marrow Transplant 1994; 13:613–617
7. Raina R, Herrera N, Krishnappa V et al. Hematopoietic stem cell transplantation and acute kidney injury in children: A comprehensive review. Pediatr Transplant 2017; 21(4):1–14. DOI:10.1111/petr.12935
8. Hazar V, Gungor O, Guven AG et al. Renal function after hematopoietic stem cell transplantation in children. Pediatric Blood & Cancer 2009; 53:197–202
9. Kist-van Holthe JE, Goedvolk CA, Brand R et al. Prospective study of renal insufficiency after bone marrow transplantation. Pediatr Nephrol 2002; 17:1032–1037
10. Patzer L, Kentouche K, Ringelmann F et al Renal function following hematological stem cell transplantation in childhood. Pediatr Nephrol 2003; 18:623–635
11. Kist-van Holthe JE, van Zwet JM, Brand R et al. Bone marrow transplantation in children: consequences for renal function shortly after and 1 year post-BMT. Bone Marrow Transplant 1998; 22:559–564
12. Ileri T, Ertem M, Ozcakar ZB et al. Prospective evaluation of acute and chroniс renal function in children following matched related donor hematopoietic stem cell transplantation. Pediatr Transplant 2010; 14: 138–144
13. Kizilbash SJ, Kashtan CE, Chavers B et al. Acute Kidney Injury and the Risk of Mortality in Children Undergoing Hematopoietic Stem Cell Transplantation. Biol Blood Marrow Transplant 2016 Jul; 22 (7):1264–1270. doi: 10.1016/j.bbmt.2016.03.014
14. Koh K-N, Sunkara A, Kang G. Acute et al. Kidney Injury in Pediatric Patients Receiving Allogeneic Hematopoietic Cell Transplantation: Incidence, Risk Factors, and Outcomes. Biology of Blood and Marrow Transplantation 2017; doi.org/10.1016/j. bbmt.2017.11.021
15. Savenkova ND, Pankov EA. Nereshennye problemy ostrogo pochechnogo povrezhdeniya u detej. Nefrologiya 2015; 19(3):9-19
16. Chukhlovin AB, Shiryaev SN, Vavilov VN i dr. Reaktivaciya-citomegaloviursnoj infekcii posle transplantacii gemopoehticheskih stvolovyh kletok zavisimost ot vozrasta i intensivnosti kondicioniruyushchej terapii. Kliniko laboratornyj konsilium 2012; 2 (42): 63–67
17. Lunde LE, Dasaraju S, Cao Q. Hemorrhagic cystitis after allogeneic hematopoietic cell transplantation: risk factors, graft source and survival. Bone Marrow Transplant 2015 Nov; 50 (11): 1432–1437. doi: 10.1038/bmt.2015.162
18. Kloos RQ, Boelens JJ, de Jong TP. Hemorrhagic cystitis in a cohort of pediatric transplantations: incidence, treatment, outcome, and risk factors. Biol Blood Marrow Transplant 2013; 19(8): 1263–1266.doi: 10.1016/j.bbmt.2013.05.014.
19. Jodele S, Davies SM, Lane A et al. Refined diagnostic and risk criteria for HSCT-associated thrombotic microangiopathy: a prospective study in children and young adults. Blood 2014; 124 (4): 645–653
20. Jodele S, Dandoy CE, Myers KC et al. New approaches in the diagnosis, pathophysiologyand treatment of pediatric hematopoieticstem cell transplantation-associated thrombotic micro-angiopathy. Transfus Apher Sci 2016 Apr; 54(2):181–190. doi: 10.1016/j.transci.2016.04.007
21. Laskin BL, Maisel J, Goebel J et al. Renal arteriolar C4d deposition: a novel characterist of hematopoietic stem cell transplantation-associated thrombotic microangiopathy. Transplantation 2013; 96:217–223
22. Ho VT, Cutler C, Carter S et al. Blood and marrow transplant clinicaltrials network toxicity committee consensus summary: thrombotic microangiopathy after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2005;11: 571–575
23. Lerner D, Dandoy C, Hirsch R et al.Pericardial effusion in pediatric SCT recipients with thrombotic microangiopathy. Bone Marrow Transplant 2014; 49:862–863
24. Jodele S, Laskin BL, Dandoy CE et al. A new paradigm: diagnosis and management of HSCT-associated thrombotic microangiopathy as multi-system endothelial injury. Blood Rev 2015; 29:191–204
25. Siami K, Kojouri K, Swisher KK et al. Thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation: an autopsy study. Transplantation 2008; 85:22–28
26. Jodele S, Fukuda T, Mizuno K. Variable eculizumab clearance requires pharmacodynamic monitoring to optimize therapy for thrombotic microangiopathy after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2016;22(2):307–315
27. Pristanskova EA, Kirgizov KI, Sidorova NV i dr. Sluchaj uspeshnoj terapii rituksimabom vtorichnogo gemolitikouremicheskogo sindroma u pacienta posle povtornoj allogennoj transplantacii gemopoehticheskih stvolovyh kletok. Rossijskij zhurnal detskoj gematologii i onkologii 2016; 3(3): 61–65
28. Abusin GA, Abu-Arja R, Bajwa RPS. Severe transplant-associated thrombotic microangiopathy in patients with hemoglobinopathies. Pediatr Blood Cancer 2017;64(9). doi: 10.1002/ pbc.26503
29. Gromova EG, Kuznetsova LS. Sindrom lizisa opuholi patogenez, klinika, profilaktika, lechenie. Onkologiya 2007 (3): 61–64.6
30. Basile C, Montanaro A. An exceptionally severe hyper-uricemia in acute renal failure caused by spontaneous tumor lysis syndrome (TLS). G Ital Nephrol 2003; 20(5):525–528
31. Novichkova GA, Ptushkin VV., Rumyantsev AG. Klinicheskie rekomendacii po pro-filaktike i lecheniyu sindroma lizisa opuholi u detej i podrostkov 2014; 4: 37–50
32. Jacobsohn DA, Vogelsang GB. Acute graft versus host disease. Orphanet J Rare Dis 2007; 2:35
33. Ball LM, Egeler RM. Acute GvHD: pathogenesis and classification. Bone Marrow Transplant 2008;41(2):58–64
34. Homma CI, Kami M, Masuo S et al. Graft-versus-host disease of the kidney after rapid tapering of cyclosporin following reduced intensity hematopoietic stem cell transplantation. Bone Marrow Transplant 2005 May; 35(9):929–930
35. Panoskaltsis-Mortari A, Price A, Hermanson JR et al. In vivo imaging of graft-versus-host-disease in mice. Blood 2004; 103: 3590–3598
36. Pidala J. Graft-vs-host disease following allogeneic he-matopoietic stem cell transplantation. Cancer Control 2011; 18 (4): 268–276
37. Porter GA, Palmer BF, Henrich WL. Clinical relevance In: DeBroe ME, Porter GA, Bennett WM, Verpooten GA eds. Clinical nephrotoxins: Renal injury from drugs and chemicals, 2nd ed Dordrecht: Kluwer Academic, 2003; 3–20
38. Savenkova ND, Chemodanova MA, Pankov EA. Ostroe povrezhdenie pochek u detej. Nefrologiya 2013;17(4):26–35
39. Cordero C, Loboda C, Clerc-Urmès I et al. Unexpected acute renal injury after highdose etoposide phosphate and total body irradiation in children undergoing hematopoietic stem cell transplantation. Pediatr Blood Cancer 2017; 64(12). doi: 10.1002/ pbc.26669
40. Baird K, Cooke K, Kirk R Schultz. Chronic Graft Versus Host Disease (GVHD) in Children. Pediatr Clin North Am 2010 Feb; 57(1): 297–322
41. Zhang C, Todorov I, Zhang Z et al. Donor CD4+ T and B cells in transplants induce chronic graft-versus-host disease with autoimmune manifestations. Blood 2006; 107(7):2993–3001
42. Colombo AA, Rusconi C, Esposito C et al. Nephrotic syndrome after allogeneic hematopoietic stem cell transplantation as a late complication of chronic graft-versus-host disease. Transplantation 2006; 27;81(8):1087–1092
43. Coppell JA, Richardson PG, Soiffer R, et al. Hepatic veno-occlusive disease following stem cell transplantation: incidence, clinical course, and outcome. Biol Blood Marrow Transplant 2010; 16: 157–168
44. Parmar V, Lewis M, Shenoy M. Ascitic fluid drainage using a peritoneal dialysis catheter to prevent and treat multi-organ dysfunction in veno-occlusive disease in children undergoing hematopoietic stem cell transplantation. Pediatr Blood Cancer 2017; 64(9) doi: 10.1002/pbc.26469
45. Thomas SE, Hutchinson RJ, DebRoy M, Magee JC. Successful renal transplantation following prior bone marrow transplantation in pediatric patients. Pediatr Transplant 2004;8:507–512
Review
For citations:
Kharisova E.R., Savenkova N.D. FEATURES OF DEVELOPMENT, COURSE AND OUTCOME OF ACUTE KIDNEY INJURY AFTER HEMOPOIETIC STEM CELL TRANSPLANTATION IN CHILDREN (LITERATURE REWIEV). Nephrology (Saint-Petersburg). 2018;22(3):18-25. (In Russ.) https://doi.org/10.24884/1561-6274-2018-22-3-18-25
Views:
1062
Email this article 